AN OPEN LABEL, INTERNATIONAL, MULTI-CENTRE, PHASE I/IIA STUDY OF LENALIDOMIDE (REVLIMID) AND ROMIDEPSIN (ISTODAX) FOR RELAPSED /REFRACTORY HODGKIN LYMPHOMA, MATURE T-CELL LYMPHOMA AND MULTIPLE MYELOMA. (RID STUDY):